La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Danimer Scientific a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Danimer Scientific..

Danimer Scientific (OTC:DNMR) Azioni, Catena delle Opzioni

Danimer Scientific

Danimer Scientific Inc creates more sustainable, more natural ways to make plastic products sold under the proprietary Nodax brand name. The company's renewable and sustainable biopolymers have helped create plastic products that are biodegradable and compostable. Danimer Scientific's products return to nature instead of polluting lands and waters. Its technology can be found in a vast array of plastic end-use products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles, among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Poland, Belgium, and other regions.

Danimer Scientific Inc Ordinary Shares - Class A

Danimer Scientific Inc

DANIMER SCIENTIFIC INC A by Danimer Scientific, Inc.

Jones Trading analyst Matthew Erdner reiterates Angel Oak Mortgage REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOMR#NYSE">AOMR</a>) with a Buy and maintains $10.5 price target.

News

Price Target

Reiteration

Analyst Ratings

AOMR

Jones Trading Reiterates Buy on Angel Oak Mortgage REIT, Maintains $10.5 Price Target

U.S. stock futures fell on Tuesday after snapping a nine-day winning streak on the S&amp;P 500 index. Futures of major benchmark indices were lower in premarket.
After a remarkable 20-year high winning streak, the S&amp;P 500 saw stocks decline on Monday. This reversal was triggered by two key statements from President Donald Trump: his proposal for a 100% tariff on <a href="https://www.benzinga.com/general/entertainment/25/05/45201601/trump-wants-movies-made-in-america-again-heres-what-tariffs-on-films-could-mean-for-disney-netflix-stock">foreign-made films</a> and his announcement that he would not be discussing trade with Chinese President Xi Jinping this week. 
Investors are keeping an eye on the Federal Reserve&#8217;s decision on interest rates, which is slated to be announced on Wednesday.
Meanwhile, the 10-year Treasury bond yielded 4.36% and the two-year bond was at 3.81%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 96.8% likelihood of the Federal Reserve keeping the current interest rates unchanged in its May meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.54%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.77%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.91%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.98%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell in premarket on Tuesday. The SPY was down 0.82% to $558.89, while the QQQ declined 1.12% to $480.49, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Energy, consumer discretionary, and information technology sectors led Monday&#8217;s decline on the S&amp;P 500, contributing to the index snapping a nine-session winning streak.
Bucking this trend, consumer staples stocks closed slightly higher.
Despite Monday&#8217;s losses, the major averages still recorded gains for the second consecutive week ended Friday: the S&amp;P 500 rose by 2.9%, the Dow by 3%, and the Nasdaq by 3.4% for the week.
In company news, Skechers U.S.A. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>) saw its shares surge over 24% following an acquisition agreement by 3G Capital at $63 per share, while Tyson Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) <a href="https://www.benzinga.com/news/25/05/45198250/tyson-shares-drop-after-mixed-quarter-with-weak-sales-solid-profit">shares fell </a>around 8% after disappointing second-quarter sales.
On the economic front, the ISM services PMI exceeded expectations, rising to 51.6 in April from March&#8217;s 50.8.
The Dow Jones index declined 99 points or 0.24% to 41,218.83, whereas the S&amp;P 500 index fell 0.64% to 5,650.38. Nasdaq Composite ended 0.74% lower at 17,844.24, and the small-cap gauge, Russell 2000, tumbled 0.82% to 2,004.26.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-0.74%</td>
<td>17,844.24</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.64%</td>
<td>5,650.38</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.24%</td>
<td>41,218.83</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.82%</td>
<td>2,004.26</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
WisdomTree senior economist Jeremy Siegel highlights the positive impact of the <a href="https://www.benzinga.com/25/05/45213790/us-dollar-depreciation-is-cushioning-the-impact-of-tariffs-on-corporate-profits-says-expert-heres-how">U.S. dollar&#8217;s decline</a> on multinational earnings this year.
In his weekly commentary, he points out that roughly half of the S&amp;P 500&#8217;s revenue is generated internationally, a factor he believes can mitigate the adverse effects of tariffs on corporate profits.
As Siegel states, "With 40-45% of S&amp;P 500 revenues sourced abroad, that currency translation effect alone could cushion the impact of tariffs on corporate profits."
He further suggests that, "This, alongside hopes of deal-making and eventual tariff de-escalation, is underpinning the market&#8217;s recovery."
Moreover, Siegel remains optimistic about stocks, explaining that markets often overreact to recessions.
He argues, "While earnings may drop if the economy turns south, the long-horizon value of equities should not fall 20–25%, as often happens. If investors finally look beyond the valley into the mountain, the downside could be limited even in a mild recession."
As the Federal Reserve is projected to keep the interest rates steady after the Wednesday&#8217;s meeting, Cooper Howard, director, fixed income strategy at the Schwab Center for Financial Research said, &#8220;The market&#8217;s pricing in between three and four cuts prior to the year-end, but that's aggressive unless the labor market shows further signs of slowing.&#8221;
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Tuesday:
<ul>
<li>The U.S. trade deficit data for March will be out by 8:30 a.m.</li>
</ul>
Stocks In Focus:
<ul>
<li>Marriott International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) rose 0.62% in premarket on Tuesday as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of $2.25 per share on revenue of $6.17 billion.</li>
</ul>
<ul>
<li>Archer-Daniels-Midland Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) fell 0.63% as Wall Street expects it to report earnings of 67 cents per share on revenue of $21.94 billion before the opening bell.</li>
</ul>
<ul>
<li>Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) was 0.59% lower as it is expected to report earnings after the closing bell. Analysts expect a quarterly earnings of 94 cents per share on revenue of $7.13 billion.</li>
</ul>
<ul>
<li>Celanese Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) jumped 5.49% after posting better-than-expected results for its first quarter on Monday. The company said it sees second-quarter adjusted earnings of $1.30 to $1.50 per share, versus market estimates of $1.41 per share.</li>
</ul>
<ul>
<li>Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) dropped 7.89% despite reporting in-line earnings for its first quarter on Monday. Palantir reported first-quarter revenue of $883.86 million, beating analyst estimates of $862.83 million. The company reported first-quarter adjusted earnings of 13 cents per share, in line with analyst estimates.</li>
</ul>
<ul>
<li>International Business Machines Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) was trading 074% lower after expanding its partnership with Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), down 1.07%. The companies aim to advance agentic AI and hybrid cloud, and also unveil hybrid AI technologies.</li>
</ul>
<ul>
<li>Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) was 11.34% higher after announcing a strategic partnership with Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) to advance autonomous mobility.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 2.78% to hover around $58.72 per barrel.
Gold Spot US Dollar rose 1.36% to hover around $3,376.57 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was lower by 0.18% at the 99.6530 level.
Asian markets were mixed on Monday. India's S&amp;P BSE Sensex and Australia's ASX 200 indices declined. While China&#8217;s CSI 300, Hong Kong's Hang Seng, Japan's Nikkei 225, and South Korea's Kospi index rose. European markets were also mixed in early trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45214653/uber-could-win-the-robo-taxi-war-says-expert-analyst-predicts-75-gains-on-ride-hailing-cost-drop">Uber Could Win The &#8216;Robo Taxi War,&#8217; Says Expert: Analyst Predicts 75% Gains On Ride Hailing Cost Drop</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Market Summary

Futures

Treasuries

Economics

Pre-Market Outlook

Markets

Trading Ideas

ORCL

PLTR

PONY

UBER

US Stocks Likely To Open Lower After Snapping 9-Day Streak: 'Downside Could Be Limited Even In A Mild Recession,' Says Expert

WestPark Capital analyst Curtis Shauger initiates coverage on Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) with a Buy rating and announces Price Target of $315.

Initiation

WDAY

WestPark Capital Initiates Coverage On Workday with Buy Rating, Announces Price Target of $315

Howard Lutnick, the U.S. Commerce Secretary, has voiced his concerns regarding the likelihood of a trade agreement with Canada ahead of a&nbsp;meeting between President&nbsp;Donald Trump and the newly elected Canadian Prime Minister&nbsp;Mark Carney on Tuesday.
What Happened: On Monday, Lutnick referred to the Canadian government as a &#8220;socialist regime&#8221; and questioned the feasibility of a trade deal with the country.
During an interview with Fox Business Network's Larry Kudlow, he pointed out that the U.S. has been disproportionately supporting the Canadian economy for decades, with American companies manufacturing cars and producing films in Canada.
He called making a deal with Canada &#8220;really complex&#8221; and stated, &#8220;They&#8217;ve been basically feeding off of us for decades upon decades upon decades.&#8221;
Lutnick expressed anticipation for the upcoming meeting between the leaders of the two nations but also voiced his doubts about its potential success. &#8220;Its going to be a fascinating meeting.&#8221; The commerce secretary added, &#8220;I just don&#8217;t see how it works out so perfectly.&#8221;
SEE ALSO:&nbsp;<a href="https://benzinga.com/25/05/45187521/buffett-tips-his-hat-to-tim-cooks-leadership-at-apple-he-has-made-berkshire-a-lot-more-money-than-ive-ever-made" target="_blank" rel="noreferrer noopener">Warren Buffett Says He Is &#8216;Embarrassed,&#8217; But &#8216;Tim Cook Has Made Berkshire A Lot More Money Than I&#8217;ve Ever Made&#8217;</a>
Why It Matters: Lutnick&#8217;s comment comes before a high-stakes meeting between the heads of the U.S. and Canada. On Friday, Canadian PM Mark Carney told reporters that he had a &#8216;very constructive&#8217; phone call with Trump and called him one of the &#8216;best negotiators&#8217;. Previously, Carney had asserted, &#8220;Our old relationship with the United States (&#8230;) is over.&#8221;
On Monday, when asked about the meeting with Carney, President Trump told reporters, &#8220;I&#8217;m not sure what he wants to see me about but I guess he wants to make a deal everybody does they all want to make a deal&#8221;
Notably, in April, Canada announced a temporary six-month relief from its countermeasure tariffs on U.S. goods, a move that signaled a de-escalation in North America&#8217;s trade standoff. The decision, which was in line with a more conciliatory tone recently struck by the Trump administration, was seen as a positive step towards easing trade tensions between the two countries.&nbsp;
However, Lutnick&#8217;s recent remarks have introduced a new level of uncertainty into the equation. As the leaders of the two nations prepare to meet, the outcome of their discussions could have significant implications for the future of U.S.-Canada trade relations.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="President Trump will change the way trade is done, Commerce secretary says" width="500" height="281" src="https://www.youtube.com/embed/zF5JJiDx32M?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/events/25/04/44971154/trump-fails-to-impress-americas-young-shows-poll-as-they-still-favor-biden-only-15-think-us-on-right-track" target="_blank" rel="noreferrer noopener">Trump Fails To Impress America&#8217;s Young, Shows Poll As They Still Favor Biden — Only 15% Think US On Right Track &#8211; Benzinga</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Government

Politics

US Commerce Secretary Lutnick Skeptical Of Trade Deal With Canada's 'Socialist Regime' Ahead Of Trump-Carney Meeting: 'They've Been Basically Feeding Off Of Us For Decades Upon Decades..'

Needham analyst Serge Belanger maintains Ocular Therapeutix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUL#NASDAQ">OCUL</a>) with a Buy and lowers the price target from $15 to $14.

OCUL

Needham Maintains Buy on Ocular Therapeutix, Lowers Price Target to $14

Haliey Welch, also known as the &#8220;Hawk Tuah Girl,&#8221; addressed the controversy surrounding her memecoin, which dropped in value shortly after launch, prompting holders to file a lawsuit against her team.&nbsp;&nbsp;
What happened: During an interview <a href="https://www.vanityfair.com/hollywood/story/haliey-welch-aka-hawk-tuah-tries-to-explain-herself">with</a> Vanity Fair on Friday, the viral influencer expressed regret and emotional distress over the incident, stating that she didn&#8217;t fully understand cryptocurrency.
"Half of those people that done it were, like, my fans. They trusted me, like, guiding them to it. And I don't know…it really hurt my feelings when it turned out the way it did. I wish it hadn't have [sic] happened," Welch said.
She admits to knowing very little about cryptocurrency and should have done more research before beginning such a venture.&nbsp;
"You got to be really careful what you tie your name to, and you definitely need to know what you're getting yourself into when you agree to do it," Welch said.&nbsp;
The ‘Hawk Tuah Girl' said she took a "much-needed" mental health break from the public eye after the controversy
See Also:<a href="https://www.benzinga.com/25/04/44621245/gold-backed-cryptos-match-yellow-metals-highs-following-trumps-liberation-day-shock"> </a><a href="https://www.benzinga.com/25/05/45187462/trump-denies-personal-profit-from-memecoin-venture-i-havent-even-looked">Trump Denies Personal Profit From Memecoin Venture: &#8216;I Haven&#8217;t Even Looked&#8217;</a>
Why It Matters: The Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)-based HAWK meme coin ballooned to a <a href="https://www.benzinga.com/general/entertainment/24/12/42333397/hawk-tuah-girl-accused-of-scamming-crypto-buyers-after-newly-launched-meme-coin-pumps-and-dumps-victims-contemplate-legal-action">$490 million market capitalization</a> shortly after its December launch before swiftly plunging 91%, leaving unsuspecting investors holding the bag.
On-chain detective Stephen Findeisen, better known as Coffeezilla, described the launch as one of the most &#8220;miserable and horrible&#8221; ever, alleging insider trading activity.
The team behind the token <a href="https://www.benzinga.com/content/42377682/coffeezilla-debunks-misleading-headlines-about-influencer-hailey-welch-and-hawk-memecoin">denied allegations of a rug pull</a>, a scam where creators raise funds for the coin, causing its value to soar only to disappear with the invested funds, leaving the project worthless.
According to a TMZ <a href="https://www.tmz.com/2025/03/27/haliey-welch-hawk-tuah-girl-meme-coin-investigation-over-sec-no-charges/">report</a> from March, Haley's attorney said that the SEC closed its investigation without taking any action against her.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45187736/elizabeth-warren-slams-shady-deal-involving-trump-family-backed-usd1-as-democrats-withdraw-support-for-senarte-crypto-bill">Elizabeth Warren Slams &#8216;Shady&#8217; Deal Involving Trump Family-Backed USD1 As Democrats Withdraw Support For Senate Crypto Bill</a></li>
</ul>
Photo courtesy: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Entertainment

$SOL

'Hawk Tuah Girl' Haliey Welch Expresses Regret Over Controversial Meme Coin Launch, Wishes It Hadn't Happened

Shares of ThredUp Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDUP#NASDAQ">TDUP</a>) rose sharply in today's pre-market trading after the company announced better-than-expected first-quarter results and <a href="https://www.benzinga.com/quote/TDUP/earnings">raised its FY25 sales forecast</a>.
ThredUp posted a quarterly loss of 4 cents per share, compared to market estimates for a loss of 7 cents per share. The company's quarterly sales came in at $71.29 million versus expectations of $68.19 million.
ThredUp shares jumped 19.6% to $5.31 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>AIFU Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIFU#NASDAQ">AIFU</a>) rose 76.4% to $0.2178 in pre-market trading after falling around 11% on Monday.</li>
<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) surged 70.6% to $1.08 in pre-market trading after jumping around 12% on Monday.</li>
<li>China SXT Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) gained 64.5% to $2.32 in pre-market trading after dipping 38% on Monday.</li>
<li>BloomZ Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) jumped 53.4% to $0.2770 in pre-market trading after gaining 8% on Monday.</li>
<li>CAMP4 THERAPEUTICS CORPORATION (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) gained 44.3% to $2.77 in pre-market trading.</li>
<li>JBDI Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBDI#NASDAQ">JBDI</a>) surged 32.5% to $1.10 in pre-market trading after announcing a $1.0 million share repurchase program.</li>
<li>Intrepid Potash, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) gained 19.4% to $38.88 in pre-market trading following first-quarter results.</li>
<li>WeRide Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRD#NASDAQ">WRD</a>) gained 13.1% to $7.75 in pre-market trading after the company announced it expanded its strategic partnership with Uber to bring autonomous vehicles to 15 additional cities.</li>
<li>Pony AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) climbed 11.8% to $10.85 in pre-market trading. PONY AI and Uber announced a strategic partnership to advance autonomous mobility.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Cadiz Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDZI#NASDAQ">CDZI</a>) shares dipped 37.4% to $1.81 in pre-market trading.</li>
<li>NuCana plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares fell 28.8% to $0.7821 in pre-market trading after jumping more than 130% on Monday.</li>
<li>BRC Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>) shares fell 24.3% to $1.79 in pre-market trading after posting a wider-than-expected quarterly loss.</li>
<li>N2OFF, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NITO#NASDAQ">NITO</a>) fell 22.7% to $0.5250 in pre-market trading after jumping 140% on Monday.</li>
<li>Digital Ally, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) declined 21.6% to $0.0250 in pre-market trading. Digital Ally, on Monday, announced a reverse stock split.</li>
<li>Energys Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENGS#NASDAQ">ENGS</a>) shares tumbled 19.1% to $2.50 in pre-market trading after dipping 66% on Monday.</li>
<li>Hyperscale Data, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#NYSE">GPUS</a>) dipped 17.2% to $6.42 in pre-market trading. Hyperscale Data shares jumped 466% on Monday after the company issued FY25 sales guidance.</li>
<li>Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) fell 8.4% to $113.45 in pre-market trading. Palantir reported in-line earnings for its first quarter on Monday. Palantir reported first-quarter revenue of $883.86 million, beating analyst estimates of $862.83 million. The company reported first-quarter adjusted earnings of 13 cents per share, in line with analyst estimates. The company also raised its full-year guidance</li>
<li>Arcus Biosciences, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCUS#NYSE">RCUS</a>) fell 7.1% to $8.31 in pre-market trading.</li>
<li>Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) fell 6.8% to $206.00 in today's pre-market trading after the company reported third-quarter results and issued fourth-quarter guidance with its midpoint below estimates.</li>
</ul>
Now Read This:
<ul>
<li><a href="https://www.benzinga.com/markets/25/05/45192607/jim-cramer-applied-materials-is-an-excellent-company-but-likes-this-tech-stock-more"> Jim Cramer Says Applied Materials Is An &#8216;Excellent&#8217; Company, But Likes This Tech Stock More</a> </li>
</ul>
Photo via Shutterstock

Movers

AIFU

BLMZ

BRCC

CAMP

CDZI

DGLY

ENGS

GPUS

JBDI

MRIN

NCNA

NITO

RCUS

SXTC

TDUP

Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Needham analyst James Ricchiuti maintains NAPCO Security Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSSC#NASDAQ">NSSC</a>) with a Buy and lowers the price target from $37 to $32.

NSSC

Needham Maintains Buy on NAPCO Security Techs, Lowers Price Target to $32

Gold prices climbed above $3,380 per ounce Tuesday, reaching a new high as investors sought safe-haven assets amid escalating trade tensions. The precious metal gained $90 in Monday&#8217;s session before adding another $45 in early trading.
What Happened: &#8220;Gold is up another $45 so far tonight, trading above $3,380. With today&#8217;s $90 gain, that&#8217;s already $135 within one 24-hour period,&#8221; noted economist Peter Schiff on X. &#8220;Silver is also starting to perk up. It&#8217;s adding another 50 cents to today&#8217;s gains, trading above $33.10. Keep an eye on silver. A breakout is near.&#8221;
The rally comes as President Donald Trump expanded tariffs, threatening 100% tariffs on foreign-produced films and announcing plans for pharmaceutical tariffs in the coming weeks. This follows already imposed steep 145% tariffs on Chinese goods that have rattled global markets.
Silver prices also surged nearly 2% to around $33 per ounce on Tuesday, extending gains from the previous session. In response to a follower suggesting silver needs to top $36 before moving to $50, Schiff replied, &#8220;I&#8217;d say a close above $35 would trigger that move.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Gold is up another $45 so far tonight, trading above $3,380. With today&#39;s $90 gain, that&#39;s already $135 within one 24-hour period. Silver is also starting to perk up. It&#39;s adding another 50 cents to today&#39;s gains, trading above $33.10. Keep an eye on silver. A breakout is near.
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1919574440033055075?ref_src=twsrc%5Etfw">May 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/05/45212767/bitcoin-ethereum-flat-dogecoin-dips-even-as-trump-calls-crypto-popular-analyst-says-btc-build-up-good-predicts-eth-uptrend-after-fed-meet">Bitcoin, Ethereum Flat, Dogecoin Dips Even As Trump Calls Crypto &#8216;Popular:&#8217; Analyst Says BTC Build-up Good, Predicts ETH Uptrend After Fed Meet</a>
Why It Matters: Investors now await the Federal Reserve&#8217;s policy decision this week. Despite pressure from Trump to lower rates, the central bank is expected to maintain current interest rates. According to the CME FedWatch tool, markets are pricing in a 97% probability of rates remaining unchanged.
Gold-backed cryptocurrencies have benefited from the metal&#8217;s performance, with PAX Gold (PAXG) and Tether Gold extending their year-to-date gains to over 28%. Meanwhile, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) has shown comparatively modest growth at just 1.24% year-to-date, now trading around $94,000.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45214653/uber-could-win-the-robo-taxi-war-says-expert-analyst-predicts-75-gains-on-ride-hailing-cost-drop">Uber Could Win The &#8216;Robo Taxi War,&#8217; Says Expert: Analyst Predicts 75% Gains On Ride Hailing Cost Drop</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with&nbsp;the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was&nbsp;reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Commodities

$BTC

Bitcoin Critic Peter Schiff Says A 'Breakout Is Near' As Gold Surges Above $3,380, Silver Starts To Perk Up

Needham analyst Quinn Bolton maintains ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) with a Buy and lowers the price target from $57 to $50.

Needham Maintains Buy on ON Semiconductor, Lowers Price Target to $50

Needham analyst Serge Belanger maintains BioCryst Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCRX#NASDAQ">BCRX</a>) with a Buy and raises the price target from $15 to $17.

BCRX

Needham Maintains Buy on BioCryst Pharma, Raises Price Target to $17

President Donald Trump signed an executive order Monday directing the Food and Drug Administration to accelerate approvals for domestic pharmaceutical manufacturing facilities as his administration prepares to <a href="https://www.benzinga.com/25/04/44708204/trump-hints-at-major-tariff-on-imported-pharmaceuticals-us-pharma-stocks-tumble-in-wednesday-pre-market">announce new tariffs on imported medicines</a> within two weeks
What Happened: The executive order aims to streamline the drug manufacturing approval process by eliminating unnecessary requirements and reducing the time needed to approve new U.S. production sites. 
According to the White House, building pharmaceutical manufacturing capacity currently takes &#8220;five to 10 years,&#8221; which it called &#8220;unacceptable from a national-security standpoint.&#8221;
&#8220;We don&#8217;t want to be buying our pharmaceuticals from other countries because if we&#8217;re in a war, we&#8217;re in a problem, we want to be able to make our own,&#8221; Trump said in a White House fact sheet.
See Also: <a href="https://www.benzinga.com/markets/25/05/45213562/peter-schiff-challenges-us-dominance-after-elon-musks-china-consumption-narrative-a-50-drop-in-the-dollar-could-supercharge-chinas-global-consumer-base">Peter Schiff Challenges US Dominance After Elon Musk&#8217;s China Consumption Narrative — A 50% Drop In The Dollar Could Supercharge China&#8217;s Global Consumer Base</a>
Why It Matters: The executive order comes as U.S. pharmaceutical manufacturing has significantly declined over decades, with most active drug ingredients now produced in China and other countries. According to EY analysis, reported by Reuters, the U.S. imported $203 billion in pharmaceutical products in 2023, with 73% coming from Europe, primarily Ireland, Germany and Switzerland.
For investors, this points to broader <a href="https://www.benzinga.com/general/biotech/25/02/43982604/eli-lilly-doubles-capital-spending-on-us-drug-manufacturing-with-50-billion-target">shifts in the pharmaceutical secto</a>r, with companies such as Eli Lilly and Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), and AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) already unveiling new domestic manufacturing plans in reaction to the looming tariff threats.
The pending tariffs could significantly impact <a href="https://www.benzinga.com/personal-finance/25/04/45029761/experts-warn-tariffs-could-negatively-impact-pretty-fragile-supply-of-generic-drugs">generic drug makers</a>, which provide 90% of U.S. prescriptions, possibly worsening existing shortages. There are already over 250 drug shortages nationwide, down from 323 in early 2024 but still concerning for healthcare stakeholders.
Mark Cuban, whose Cost Plus Drugs company sells medications at substantial discounts, warned the tariffs could force <a href="https://www.benzinga.com/news/25/04/44658207/mark-cuban-says-cost-plus-drugs-faces-price-hike-threat-tariffs-would-force-us-to-pass-costs-directly-to-consumers">price increases on many drugs</a>: &#8220;If we have a high tariff on drugs coming from India, we won&#8217;t have a choice but to pass those costs on to consumers.&#8221;
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45213365/maxine-waters-to-obstruct-cryptocurrency-hearing-plans-shadow-hearing-instead">Maxine Waters Plans Walkout From Crypto Hearing, Will Host &#8216;Shadow Hearing&#8217; Opposing Trump Family Ventures: Report</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Image Via Shutterstock

Regulations

Health Care

ABBV

Trump Orders FDA To Fast-Track US Drug Production As Tariff Threat Looms On Imported Medicines: Cites National Security Concerns

Needham analyst Gil Blum maintains Recursion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) with a Buy and lowers the price target from $11 to $8.

RXRX

Needham Maintains Buy on Recursion Pharmaceuticals, Lowers Price Target to $8

Macro Economic Events

Econ #s

U.K. Services Purchasing Managers Index For April 49.0 Vs. 48.9 Est.; 52.5 Prior

U.K. Composite Purchasing Managers' Index For April 48.5 Vs. 48.2 Est.; 51.5 Prior

Eurozone Services Purchasing Managers Index For April 50.1 Vs. 49.7 Est.; 51.0 Prior

Billionaire hedge‑fund manager Bill Ackman expects Washington's trade fight to fade quickly, stating that tariffs will amount to "a one‑time reset" rather than a new wave of inflation.
What Happened: &#8220;The important thing is the tariffs get resolved in the relative short term,&#8221; the Pershing Square CEO said, <a href="https://www.cnbc.com/2025/05/05/cnbc-excerpts-pershing-square-ceo-bill-ackman-speaks-with-cnbcs-andrew-ross-sorkin-on-squawk-box-today.html">speaking</a> at CNBC's &#8220;Squawk Box&#8221;. &#8220;If we're still dealing with the tariff thing as major headlines, that uncertainty will weigh on Q2.&#8221; Ackman argued that higher import duties would lift some prices, but unlike runaway inflation, the bump would not &#8220;compound.&#8221;
He sees a softer economy already taking shape. &#8220;I think inflation has largely been wrung out,&#8221; Ackman said, pointing to falling egg and energy costs. With price pressures cooling, he believes the Federal Reserve could begin trimming rates "toward the end of the year,&#8221; adding that &#8220;a small cut relatively soon … makes sense.&#8221;
Ackman blamed early‑year strength on &#8220;front‑loading of purchases&#8221; as companies tried to beat the Trump administration's 145% China tariff. <a href="https://www.benzinga.com/25/04/44616760/donald-trump-sets-reciprocal-tariffs-on-key-trade-partners-in-historic-policy-shock">&#8220;Liberation Day&#8221; uncertainty</a>, he said, prompted many firms to pause spending, momentum he expects to show up in second‑quarter data.
See also: <a href="https://www.benzinga.com/25/05/45213790/us-dollar-depreciation-is-cushioning-the-impact-of-tariffs-on-corporate-profits-says-expert-heres-how">US Dollar Depreciation Is Cushioning &#8216;The Impact Of Tariffs On Corporate Profits,&#8217; Says Expert</a>
On China policy, the investor urged a tempered approach: &#8220;The right thing to do is we pause on China — maybe 180 days," giving both sides room to strike a deal while U.S. companies shift supply chains.
Ackman has long criticized the Fed for keeping rates too high and famously <a href="https://www.benzinga.com/government/23/08/33547572/hedge-fund-guru-bill-ackman-bets-against-us-treasuries-expects-30-year-yields-to-surge-to-5-5">placed a bet</a> on falling Treasury yields in 2023. He says the bond market already senses a cooling economy this time, leaving policymakers little reason to wait.
Why It Matters: Ackman, last week, urged Trump on X to <a href="https://www.benzinga.com/markets/25/05/45160204/bill-ackman-presses-trump-to-pause-china-tariffs-says-time-becomes-our-friend-if-pressure-on-us-economy-is-lifted">suspend China tariffs</a>, saying they saddle U.S. firms with higher costs and drain Washington's leverage at the bargaining table. A pause, he argued, would flip the pressure onto Beijing because "every U.S. business is already moving its supply chain and manufacturing out of China."
 Ackman, who once endorsed Trump yet now <a href="https://www.benzinga.com/personal-finance/25/04/44778587/we-are-heading-for-a-self-induced-economic-nuclear-winter-billionaire-investor-bill-ackman-has-turned-on-trump-over-tariffs?utm_source=chatgpt.com">brands the duties</a> an "economic nuclear winter", issued the plea days after the White House hiked China levies to 125 percent while granting a 90‑day reprieve to non‑retaliating nations. He warned that smaller companies, lacking the cash buffers of multinationals, could <a href="https://www.benzinga.com/news/global/25/04/44723751/billionaire-investor-bill-ackman-praises-trumps-tariff-pause-thank-you-on-behalf-of-all-americans">buckle under prolonged tariffs</a>, undermining the economy Trump aims to shield.
Read next: <a href="https://www.benzinga.com/news/25/05/45214328/mike-pence-warns-trumps-indiscriminate-tariffs-could-trigger-price-shock-and-potential-shortages-keeping-our-kids-toys-affordable-is-part-of-the-american-dream">Mike Pence Warns Trump&#8217;s &#8216;Indiscriminate&#8217; Tariffs Could Trigger &#8216;Price Shock&#8217; And Potential Shortages: &#8216;Keeping Our Kids&#8217; Toys Affordable&#8230;Is Part Of The American Dream&#8217;</a>

Global

General

Bill Ackman Calls Tariffs A 'One Time Reset,' Warns Prolonged China Fight Could Drag Market Slump To Q2

HCOB Eurozone Composite Purchasing Managers Index For April 50.4 Vs. 50.1 Est.; 50.9 Prior

Germany Services Purchasing Managers Index For April 49.0 Vs. 48.8 Est.; 50.9 Prior

France Services Purchasing Managers Index For April 47.3 Vs. 46.8 Est.; 47.9 Prior

Press Releases

DoD Makes Award to Danimer Scientific via the Distributed Bioindustrial Manufacturing Program

Ningbo Homelink Eco-iTech and Danimer Scientific Announce Commercial Launch of Home Compostable Extrusion Coating Biopolymer Based on PHA

Danimer Scientific Names Richard Altice Interim CEO

Danimer Scientific Announces Second Circuit Court Affirms Dismissal of Class Action Lawsuit

Danimer Scientific Announces Intention to Complete a Reverse Stock Split

Danimer Scientific Announces Release Date for Third Quarter 2024 Results

Danimer Scientific Announces Third Quarter 2024 Results

TerraNova Capital Equities announces three transactions totaling $45 Million

Danimer Scientific Takes Action to Strengthen Capital Structure

Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace

Comments

Danimer Scientific

Danimer Scientific (DNMR) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO